Literature DB >> 21398192

Quantification of steroid glycosides from Hoodia gordonii in porcine plasma using high performance liquid chromatography-mass spectrometry.

Chris J van Platerink1, Hans-Gerd M Janssen, Brigitte Graf, Leo Abrahamse, Johan Haverkamp.   

Abstract

An HPLC-ESI-MS/MS method using collision induced dissociation - multiple reaction monitoring was developed for the quantification of eight Hoodia gordonii steroid glycosides and their metabolites in porcine plasma samples. The method was validated for the three most important glycosides and was successfully applied also for the related glycosides and metabolites. The limits of quantification were 0.04 ng ml(-1) for the two main steroid glycosides and 0.1 ng ml(-1) for the detiglated metabolites. These limits are sufficiently low to allow monitoring the concentration-time profiles in plasma after feeding H. gordonii. The standard deviations of the intra-day measurements were better than 20% for concentrations below 5 ng ml(-1) and better than 10% for concentrations above 5 ng ml(-1). The method was successfully applied to plasma samples collected from a porcine pharmacokinetics study.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398192     DOI: 10.1016/j.jchromb.2011.02.026

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Lithium ion adduction enables UPLC-MS/MS-based analysis of multi-class 3-hydroxyl group-containing keto-steroids.

Authors:  Qiuyi Wang; Kimiko Shimizu; Kanako Maehata; Yue Pan; Koki Sakurai; Takatoshi Hikida; Yoshitaka Fukada; Toshifumi Takao
Journal:  J Lipid Res       Date:  2020-02-26       Impact factor: 5.922

2.  Sympathomimetic activity of a Hoodia gordonii product: a possible mechanism of cardiovascular side effects.

Authors:  Orsolya Roza; Norbert Lovász; István Zupkó; Judit Hohmann; Dezső Csupor
Journal:  Biomed Res Int       Date:  2013-11-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.